BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25327141)

  • 1. Structure of the lysine specific protease Kgp from Porphyromonas gingivalis, a target for improved oral health.
    Gorman MA; Seers CA; Michell BJ; Feil SC; Huq NL; Cross KJ; Reynolds EC; Parker MW
    Protein Sci; 2015 Jan; 24(1):162-6. PubMed ID: 25327141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights unravel the zymogenic mechanism of the virulence factor gingipain K from
    Pomowski A; Usón I; Nowakowska Z; Veillard F; Sztukowska MN; Guevara T; Goulas T; Mizgalska D; Nowak M; Potempa B; Huntington JA; Potempa J; Gomis-Rüth FX
    J Biol Chem; 2017 Apr; 292(14):5724-5735. PubMed ID: 28196869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and mechanism of cysteine peptidase gingipain K (Kgp), a major virulence factor of Porphyromonas gingivalis in periodontitis.
    de Diego I; Veillard F; Sztukowska MN; Guevara T; Potempa B; Pomowski A; Huntington JA; Potempa J; Gomis-Rüth FX
    J Biol Chem; 2014 Nov; 289(46):32291-32302. PubMed ID: 25266723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.
    Akiyama T; Miyamoto Y; Yoshimura K; Yamada A; Takami M; Suzawa T; Hoshino M; Imamura T; Akiyama C; Yasuhara R; Mishima K; Maruyama T; Kohda C; Tanaka K; Potempa J; Yasuda H; Baba K; Kamijo R
    J Biol Chem; 2014 May; 289(22):15621-30. PubMed ID: 24755218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gingipain aminopeptidase activities in Porphyromonas gingivalis.
    Veillard F; Potempa B; Poreba M; Drag M; Potempa J
    Biol Chem; 2012 Dec; 393(12):1471-6. PubMed ID: 23667904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the phosphatidylinositol 3-kinase/Akt signaling pathway by Porphyromonas gingivalis gingipains RgpA, RgpB, and Kgp.
    Nakayama M; Inoue T; Naito M; Nakayama K; Ohara N
    J Biol Chem; 2015 Feb; 290(8):5190-5202. PubMed ID: 25564612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterisation of recombinant His-tagged RgpB gingipain from Porphymonas gingivalis.
    Veillard F; Potempa B; Guo Y; Ksiazek M; Sztukowska MN; Houston JA; Koneru L; Nguyen KA; Potempa J
    Biol Chem; 2015 Apr; 396(4):377-84. PubMed ID: 25720118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor.
    Curtis MA; Aduse Opoku J; Rangarajan M; Gallagher A; Sterne JA; Reid CR; Evans HE; Samuelsson B
    Infect Immun; 2002 Dec; 70(12):6968-75. PubMed ID: 12438376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice.
    Bittner-Eddy PD; Fischer LA; Costalonga M
    Mol Oral Microbiol; 2013 Dec; 28(6):452-66. PubMed ID: 23945018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propeptide-mediated inhibition of cognate gingipain proteinases.
    Huq NL; Seers CA; Toh EC; Dashper SG; Slakeski N; Zhang L; Ward BR; Meuric V; Chen D; Cross KJ; Reynolds EC
    PLoS One; 2013; 8(6):e65447. PubMed ID: 23762374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine gingipain (kgp) biovars of Porphyromonas gingivalis exhibit differential distribution on oral mucosal sites.
    Nadkarni MA; Chhour KL; Browne G; Jacques NA; Hunter N
    J Clin Microbiol; 2009 Oct; 47(10):3350-2. PubMed ID: 19675219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine.
    Nakagawa T; Saito A; Hosaka Y; Ishihara K
    Keio J Med; 2003 Sep; 52(3):158-62. PubMed ID: 14529148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibition.
    Yongqing T; Potempa J; Pike RN; Wijeyewickrema LC
    Adv Exp Med Biol; 2011; 712():15-29. PubMed ID: 21660656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The K1K2 region of Lys-gingipain of Porphyromonas gingivalis blocks induction of HLA expression by gamma interferon.
    Yun PL; Li N; Collyer CA; Hunter N
    Infect Immun; 2012 Oct; 80(10):3733-41. PubMed ID: 22802347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model.
    O'Brien-Simpson NM; Paolini RA; Reynolds EC
    Infect Immun; 2000 Jul; 68(7):4055-63. PubMed ID: 10858222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HA2 haemagglutinin domain of the lysine-specific gingipain (Kgp) of Porphyromonas gingivalis promotes micro-oxo bishaem formation from monomeric iron(III) protoporphyrin IX.
    Smalley JW; Birss AJ; Szmigielski B; Potempa J
    Microbiology (Reading); 2006 Jun; 152(Pt 6):1839-1845. PubMed ID: 16735746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein modifications by gingipains of Porphyromonas gingivalis.
    Lönn J; Ljunggren S; Klarström-Engström K; Demirel I; Bengtsson T; Karlsson H
    J Periodontal Res; 2018 Jun; 53(3):403-413. PubMed ID: 29341140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modular structure of haemagglutinin/adhesin regions in gingipains of Porphyromonas gingivalis.
    Li N; Yun P; Jeffries CM; Langley D; Gamsjaeger R; Church WB; Hunter N; Collyer CA
    Mol Microbiol; 2011 Sep; 81(5):1358-73. PubMed ID: 21812842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Acetyltransferase PG1842 in Gingipain Biogenesis in Porphyromonas gingivalis.
    Mishra A; Roy F; Dou Y; Zhang K; Tang H; Fletcher HM
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249709
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural determinants of inhibition of Porphyromonas gingivalis gingipain K by KYT-36, a potent, selective, and bioavailable peptidase inhibitor.
    Guevara T; Rodríguez-Banqueri A; Lasica AM; Ksiazek M; Potempa BA; Potempa J; Gomis-Rüth FX
    Sci Rep; 2019 Mar; 9(1):4935. PubMed ID: 30894633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.